Clinical Trials on Metabolic Diseases in New Zealand

Total 43860 results

AtaCor Medical, Inc.

Completed

AtaCor Subcostal Temporary Extravascular Pacing III Study (STEP III)

Conduction Defect

New Zealand, Paraguay, Czechia
Monash Medical Centre
Monash University; University of Auckland, New Zealand; Hudson Institute of Medical... and other collaborators

Recruiting

Anakinra for Preterm Infants Pilot

Inflammation | Prematurity; Extreme

Australia, New Zealand
GlaxoSmithKline

Completed

A Study to Investigate the Effect of Inhaling Single Doses of Different Formulations of GW642444M in Asthmatic Patients

Pulmonary Disease, Chronic Obstructive

Australia, New Zealand
Gilead Sciences

Completed

Safety, Tolerability and Antiviral Activity of Selgantolimod in Virally-Suppressed Participants With Chronic Hepatitis B

Chronic Hepatitis B

United States, New Zealand
Fisher and Paykel Healthcare

Completed

The Evaluation of an Interface for the Treatment of Obstructive Sleep Apnea (OSA)

Obstructive Sleep Apnea | Sleep Disordered Breathing

New Zealand
Amgen

Completed

Reduction of LDL-C With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study-2 (RUTHERFORD-2)

Hyperlipidemia

Canada, France, Netherlands, United Kingdom, New Zealand, South Africa, Spain, United States, Australia, Germany, Sweden, Hong Kong, Switzerland, Norway
Western Sydney Local Health District

Completed

Metformin in Preventing Androgen Deprivation Therapy Induced Insulin Resistance and Metabolic Syndrome (MVENT)

Metabolic Syndrome | Hypercholesterolemia

Australia
Hoffmann-La Roche

Completed

A Dose-Finding Study of Subcutaneous Herceptin (Trastuzumab) in Healthy Male Volunteers and Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Females

Breast Cancer

New Zealand, Australia
NYU Langone Health

Completed

Behavioral Management of Phosphorus in Hemodialysis Patients

Hyperphosphatemia | Cardiovascular Disease (CKD)

United States
Fresenius Medical Care North America
Renal Research Institute

Completed

Phosphate Kinetic Modeling 2 (PKM2)

ESRD | Hyperphosphatemia

United States
Medtronic - MITG

Completed

Comparison Between Pyloric Preserving and Non-Pyloric Preserving Bariatric Surgery With Glucose Challenge

Obesity | Hypoglycemia

United States
Antisoma Research

Completed

Study of AS1409 in Patients With Either Metastatic Renal Cell Carcinoma or Metastatic Malignant Melanoma

Metastatic Renal Cell Carcinoma | Metastatic Malignant Melanoma

United Kingdom, New Zealand
Biogen

No longer available

Expanded Access Program (EAP) for Nusinersen in Participants With Infantile-onset (Consistent With Type 1) Spinal Muscular Atrophy (SMA)

Infantile-onset Spinal Muscular Atrophy

New Zealand, Colombia, Turkey
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Evaluation of the Effect of Hypoglycemia With PET and a Norepinephrine Transporter Ligand

Hypoglycemia

United States
Hoffmann-La Roche

Completed

A Study of Peginterferon Alfa-2a in Participants With Chronic Hepatitis B Virus (HBV) in an Expanded Access Program

Hepatitis B, Chronic

New Zealand
Antipodean Pharmaceuticals, Inc.

Completed

A Trial of MitoQ for the Treatment of People With Parkinson's Disease

Parkinson's Disease

New Zealand, Australia
Bayhill Therapeutics

Completed

Phase 1 Study of BHT-3021 in Subjects With Type 1 Diabetes Mellitus

Hypoglycemia | Diabetes

Australia, United States, New Zealand
Rutgers, The State University of New Jersey
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Exercise Dose and Metformin for Vascular Health in Adults With Metabolic Syndrome

Metabolic Syndrome | Vascular Stiffness | Insulin Sensitivity

United States
Micell Technologies

Completed

First-In-Human Trial of the MiStent Drug-Eluting Stent (DES) in Coronary Artery Disease (DESSOLVE-I)

Coronary Artery Disease

Belgium, Australia, New Zealand
The University of New South Wales

Terminated

The ABSORB Bioresorbable Scaffold Below the Knee (BTK) Study

Ischemia | Arterial Occlusive Diseases | Peripheral Arterial Disease (PTA

New Zealand, Australia, Netherlands
Dartmouth-Hitchcock Medical Center

Completed

Dietary Impact on Continuous Glucose Monitoring

Glucose Metabolism Disorders | Dietary Habits | Pediatric ALL | Adult ALL

United States
Sanofi
Regeneron Pharmaceuticals

Completed

Effect of Alirocumab on Lipid Metabolism in Adults With Elevated LDL-Cholesterol

Hypercholesterolemia

United States
NYU Langone Health

Completed

Using Nudges to Implement Comparative Effectiveness

Hypercholesterolemia

United States
National University Hospital, Singapore
Monash University; Tan Tock Seng Hospital; University of Otago; Changi General... and other collaborators

Unknown

Renal Denervation in Heart Failure Patients With Preserved Ejection Fraction (RESPECT-HF) (RESPECT-HF)

Heart Failure

Singapore, New Zealand, Australia
ChemoCentryx

Completed

A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Germany, New Zealand, Hungary, Czechia, Australia
Yale University
American Diabetes Association

Completed

Investigating the Role of the Polyol Pathway in the Central Nervous System

Hyperglycemia

United States
Atlantic Health System

Terminated

Evaluation of an ICU Hyperglycemia Protocol Using Insulin Aspart

Hyperglycemia

United States
Golden Biotechnology Corporation

Completed

Trial of Antroquinonol in Patients With Hypercholesterolemia and Hyperlipidemia

Hyperlipidemias

Taiwan
Pfizer

Completed

Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 As Oral Monotherapy To Treat Adults With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type II

United States
Arrowhead Pharmaceuticals

Active, not recruiting

Study of ARO-APOC3 in Adults With Dyslipidemia

Dyslipidemias

United States, Australia, Canada, Poland, Netherlands, New Zealand, Hungary
Arrowhead Pharmaceuticals

Recruiting

Study of ARO-MMP7 Inhalation Solution in Healthy Subjects and Patients With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

Denmark, New Zealand, Spain
Ardea Biosciences, Inc.

Completed

Phase 2a RDEA3170 and Allopurinol Combination Study in Gout Subjects

Gout

United States
Institute of Liver and Biliary Sciences, India

Completed

Effect of Preoperative Carbohydrate Loading on Post-operative Insulin Resistance After Donor Hepatectomy.

Healthy

India
NYU Langone Health
Genzyme, a Sanofi Company

Completed

Genzyme Osteopenia/Osteoporosis Study

Gaucher Disease

United States
Dicerna Pharmaceuticals, Inc.

Completed

A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluria Type 2 (PHYOX2)

Kidney Diseases | Urologic Diseases | Genetic Disease | Primary Hyperoxaluria Type 1 (PH1) | Primary Hyperoxaluria Type 2 (PH2)

Poland, United Kingdom, New Zealand, United States, Australia, Canada, France, Germany, Israel, Italy, Japan, Lebanon, Netherlands, Romania, Spain
Hoffmann-La Roche

Completed

A Study of Ritonavir-Boosted Danoprevir (RO5190591) in Combination With Pegasys and Ribavirin in Patients With Chronic Hepatitis C Genotype 1

Hepatitis C, Chronic

New Zealand, Poland, France
Hoffmann-La Roche

Completed

A Study of Combination Treatment With an HCV Polymerase Inhibitor (RO5024048) and an HCV Protease Inhibitor (RO5190591/Danoprevir) in Genotype 1 Chronic Hepatitis C Patients

Hepatitis C, Chronic

New Zealand, Australia
Northwell Health
Novartis

Completed

Iron Overload in Pediatric Oncology Patients

Iron Overload

United States
Kirby Institute
National Heart, Lung, and Blood Institute (NHLBI); The University of New South... and other collaborators

Completed

Pravastatin for Hyperlipidaemia in HIV.

HIV Infections | Cardiovascular Disease | Lipodystrophy | Glucose Metabolism | Lipid Metabolism | Metabolic Abnormality

Australia
Icahn School of Medicine at Mount Sinai

Not yet recruiting

Frequency of Glucose Monitoring in Labor

Neonatal Hypoglycemia

United States
Rockefeller University

Completed

Study of the Reversibility of Glucose Intolerance Caused by Chronic Aspartame Consumption

Glucose Metabolism Disorder

United States
Jamia Hamdard University

Completed

Clinical Study to Evaluate Antihyperlipidemic Effect of a Classical Unani Antiobesity Formulation

Hyperlipidemia

India
Abbott Medical Devices

Completed

ABSORB Clinical Investigation, Cohort A (ABSORB A) Everolimus Eluting Coronary Stent System Clinical Investigation (ABSORB A)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

New Zealand, Denmark, Poland, Netherlands
Endospan Ltd.

Completed

The NEXUS™ Compassionate Use Data Collection Study

Aortic Arch Aneurysm

Switzerland, Italy, New Zealand
Cagent Vascular LLC

Completed

PRospective Study for the TrEatment of Atherosclerotic Lesions in the Superficial Femoral and/or Popliteal Arteries Using the Serranator DevicE (PRELUDE)

Peripheral Arterial Disease

New Zealand, Austria, Poland
AstraZeneca

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Moderate to Severe Psoriasis

Psoriasis

Australia, New Zealand
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Bioavailability Study for New Atorvastatin Formulation

Hypercholesterolemia

United States
Sanofi
Regeneron Pharmaceuticals

Completed

Injection Site Tolerability, Safety, Pharmacokinetics and Pharmacodynamics Study After a Single Dose Subcutaneous Treatment of Alirocumab SAR236553 (REGN727)

Hypercholesterolemia

United States
Sanofi
Regeneron Pharmaceuticals

Completed

Injection Site Tolerability, Safety, Pharmacokinetics, Pharmacodynamics in Different Single-Dose Treatments of Alirocumab SAR236553 (REGN727) in Healthy Subjects

Hypercholesterolemia

United States
Northwell Health
Staten Island University Hospital

Completed

Pre-admission Hyperglycemia and Its Effect on Morbidity and Mortality

Hyperglycemia

United States

Clinical Trials on Metabolic Diseases in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo, DR of

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations